Ezgi Özkıran

Ezgi Özkıran

Auto-generated profile, based on publicly available information

Ezgi Özkıran


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2025 in Journal of Clinical and Translational Pathology
Verified
Journal Article
Open access
NÇNesibe Kahraman Çetin
Nesibe Kahraman Çetin
EÖEzgi Özkıran
Ezgi Özkıran
STSinan Can Taşan
Sinan Can Taşan
DADilara Akın
Dilara Akın
İEİbrahim Halil Erdoğdu
İbrahim Halil Erdoğdu
İMİbrahim Meteoglu
İbrahim Meteoglu
Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation sequencing (NGS), the disease is challenging to treat due to the limited number of detectable mutations for targeted drug therapy. This study aimed to evaluate the mutation profiles of LSCC detected by NGS to assess the relationships between different driver mutations and clinicopathological parameters.

7 October 2026 in Food Science & Nutrition
Verified
Journal Article
Open access
PDF file
AYADEM YAVAS
ADEM YAVAS
EÖEzgi Özkiran
Ezgi Özkiran
EAEcem Akan
Ecem Akan
Gastric ulcer pathogenesis involves inflammation and cell death. Paraprobiotics are emerging as safer therapeutic alternatives. This study aimed to investigate the gastroprotective effect of paraprobiotics derived from Bifidobacterium animalis subsp. lactis BB‐12 and its role in modulating PANoptosis in the experimental ulcer model. Gastric ulcers were induced in Balb/c mice using indomethacin. Mice were pre‐treated by oral gavage with live B. animalis subsp. lactis BB‐12 probiotic (1 × 10 9 CFU/mL, 200 μL), its heat‐inactivated paraprobiotic (1 × 10 9 CFU/mL, 200 μL), or lansoprazole (30 mg/kg), each administered 5 min before ulcer induction with indomethacin (25 mg/kg). Gastric damage was assessed macroscopically and histologically. Oxidative stress markers (superoxide dismutase [SOD], catalase [CAT], reduced glutathione [GSH], malondialdehyde [MDA]), myeloperoxidase (MPO) activity, and serum cytokines (tumor necrosis factor‐α [TNF‐α], interleukin‐6 [IL‐6], IL‐10) were measured. Key proteins of the PANoptosis pathway were analyzed by Western blot. Both probiotic and paraprobiotic treatments significantly reduced the ulcer area (from 52.54% in the ulcer group to 21.57% and 17.34%, respectively) and the total histological damage index (from 3.95 to 1.27 and 0.95, respectively) ( p < 0.001). Both treatments reversed the depletion of antioxidant enzymes and the increase in MDA and MPO levels. Additionally, they restored IL‐10 to control levels while suppressing TNF‐α and IL‐6 ( p < 0.001). Paraprobiotics also strongly inhibited key regulatory proteins in three cell death pathways, including NLRP3, c‐Caspase‐1/3/8, ZBP1, and p‐RIPK3/MLKL. Paraprobiotics derived from B. lactis subsp. lactis BB‐12 exhibit a potent gastric protective effect against gastric ulcers. As they were administered before ulcer induction, paraprobiotics represent a promising prophylactic strategy for the prevention of inflammatory gastrointestinal disorders, identifying PANoptosis as an important therapeutic target.